Rare breast cancer poses new set of challenges

by Serena Gordon, Healthday Reporter
Rare breast cancer poses new set of challenges
Experts say standard diagnostic and treatment methods don't work for inflammatory breast cancer.

(HealthDay)—No doubt the ubiquitous pink ribbons, along with walks and races and the designation of October as National Breast Cancer Awareness Month, have focused the public eye on breast cancer and helped fund research for a cure.

But chances are good that most people still haven't heard of a particularly aggressive type of the disease known as inflammatory breast cancer.

Though rare, involving 1 to 5 percent of breast cancer cases, according to the U.S. , inflammatory breast cancer poses significant hurdles. Mammograms often aren't effective in detecting this type of cancer because there may be no discernible lump. Also, standard breast cancer treatments aren't always effective for inflammatory breast cancer.

"This disease develops quickly over a few weeks," explained Dr. Massimo Cristofanilli, a professor of medicine and director of translational medicine at Fox Chase Cancer Center in Philadelphia. "This cancer has the capacity to spread to the lymph nodes and distant sites quickly."

The exact cause of inflammatory breast cancer is unknown, he said. According to the cancer institute, it usually develops in the cells that line the milk ducts and then spreads to other areas.

The primary symptoms are redness and noticeable swelling. Cristofanilli said that skin on the breast can resemble that of an orange peel. The disease is named inflammatory breast cancer because the breast looks inflamed. The swelling occurs because the lymph vessels in the skin become blocked and fluid doesn't drain properly.

"Most women will present rapidly with an engorged breast. Their bra won't fit anymore," said Dr. Naoto Ueno, executive director of the Morgan Welch Inflammatory Program and Clinic, and a professor in the department of breast medical oncology at the University of Texas M.D. Anderson Cancer Center in Houston.

"At this point, women often go to a primary care physician," Ueno said. "They will usually diagnose mastitis, an infection of the breast. If you've had one to two weeks of antibiotics, and you're not getting better, it could be inflammatory breast cancer, and you should have a biopsy." A biopsy of breast tissue can confirm a diagnosis.

Cristofanilli said that "women need to remember that mammogram is not helpful for inflammatory breast cancer, so there's usually no early diagnosis." That factor combined with the aggressive nature of the disease means that the cancer often has metastasized, or spread to other parts of the body, by the time a woman sees a cancer specialist.

"Making a diagnosis and getting a biopsy quickly are critical," he said.

The average survival for women diagnosed with inflammatory breast cancer is about three years, Cristofanilli said. For someone whose cancer has spread beyond breast tissue but not to distant sites, considered a stage 3 cancer, the average survival time extends to about five years with the latest multi-disciplinary care.

Ueno confirmed that many of the currently available treatments don't do a great job with inflammatory breast cancer. "With stage 4 inflammatory breast cancer, the five-year survival is only 30 to 40 percent," even with the best available treatment, he said. Stage 4 cancer has spread to distant sites, such as the lungs or brain.

Both experts said it's important to seek care at a center with a lot of experience in treating inflammatory breast cancer. For a woman who doesn't live close to such a center, Ueno suggested that she visit for an initial diagnosis and treatment plan and then arrange for the center's specialists to work with her local cancer experts.

The first treatment for inflammatory breast cancer is chemotherapy, and possibly hormone therapy, according to Ueno and Cristofanilli. The goal is to eliminate any signs of the disease before doing a mastectomy. Because inflammatory usually involves the whole breast, and doesn't generally cause a lump, mastectomy is the only surgical option. Ueno said that surgery is usually followed by aggressive radiation.

If recurs after treatment, both experts suggested checking into clinical trials because researchers are constantly trying to find better ways to treat this type of cancer.

As with any cancer, the earlier it's detected, the better.

"If you have any redness or swelling, see a breast specialist right away," Cristofanilli urged. "Don't delay."

More information: The American Cancer Society has more on inflammatory breast cancer.

A companion article details a survivor's story.

Related Stories

Breast cancer more aggressive among obese women

Mar 14, 2008

Women with breast cancer have more aggressive disease and lower survival rates if they are overweight or obese, according to findings published in the March 15 issue of Clinical Cancer Research, a journal of the American Associ ...

Inflammatory breast cancer focus of new report

Oct 19, 2010

A rare and deadly form of breast cancer that often goes unrecognized by clinicians and patients alike is the focus of a new report from leading researchers. Inflammatory breast cancer (IBC) has made headlines as an unrecognized ...

Breast cancer type linked to paternal cancer

Nov 28, 2011

The risk of breast cancer is increased by genetic and lifestyle factors such as the inherited BRCA2 gene, age of having first child, or use of hormone replacement therapy (HRT). New research published in BioMed Central's ...

Recommended for you

Renewed hope in a once-abandoned cancer drug class

1 hour ago

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

Finding the way to lung tumours by 'GPS'

3 hours ago

The innumerable divisions of the bronchi often turn the hunt for tumours in the lungs into a game of chance. But soon, lung specialists will be able to navigate accurately inside the airways by "GPS".

Study suggests new approach to fight lung cancer

18 hours ago

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

User comments

More news stories

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.

Paralysed with fear: The story of polio

Thanks to vaccination, polio has been pushed to the brink of extinction – but can we finish the job? This is one of the big questions which a Bristol academic addresses in his new book, published next week.

Laughing gas does not increase heart attacks

(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk ...

Model recreates wear and tear of osteoarthritis

(Medical Xpress)—There's a reason osteoarthritis is often called wear-and-tear arthritis: Repeated stress on joints over time results in degeneration of the soft cartilage that normally distributes loads ...

Taxing unhealthy food spurs people to buy less

Labeling foods and beverages as less-healthy and taxing them motivates people to make healthier choices, finds a recent study in the American Journal of Preventive Medicine. When faced with a 30 percent tax on ...